We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$51.4B
AUM Growth
+$1.46B
(+2.9%)
Cap. Flow
+$987M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
18.85%
Holding
2,686
New
375
Increased
1,038
Reduced
898
Closed
357
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$512M |
| 2 |
Advanced Micro Devices
AMD
|
+$401M |
| 3 |
Roblox
RBLX
|
+$384M |
| 4 |
TSMC
TSM
|
+$371M |
| 5 |
TJX Companies
TJX
|
+$271M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$569M |
| 2 |
Walmart Inc
WMT
|
+$553M |
| 3 |
Meta Platforms (Facebook)
META
|
+$494M |
| 4 |
Johnson & Johnson
JNJ
|
+$395M |
| 5 |
Netflix
NFLX
|
+$383M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.47% |
| 2 | Consumer Discretionary | 14.55% |
| 3 | Financials | 14.39% |
| 4 | Healthcare | 12.45% |
| 5 | Industrials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Montauk Renewables
MNTK
$266M
| $28.1K | ﹤0.01% |
16,800
+6,500
| +63% | +$12.5K |
|
2302
Cibus
CBUS
$130M
| $27.9K | ﹤0.01% |
+16,016
| New | +$23.9K |
|
2303
Leslie's
LESL
$11.6M
| $27.3K | ﹤0.01% |
16,520
-70,300
| -81% | -$228K |
|
2304
GEE Group
JOB
$23.4M
| $26.9K | ﹤0.01% |
137,800
| – | – |
|
2305
Pyxis Oncology
PYXS
$165M
| $26K | ﹤0.01% |
22,624
-29,900
| -57% | -$105K |
|
2306
ECARX Holdings
ECX
$393M
| $24.6K | ﹤0.01% |
14,300
+2,377
| +20% | +$4.82K |
|
2307
ProKidney
PROK
$308M
| $24.4K | ﹤0.01% |
+10,900
| New | +$28.7K |
|
2308
Galmed Pharmaceuticals
GLMD
$3.94M
| $23.6K | ﹤0.01% |
+31,491
| New | +$36.8K |
|
2309
Millennium Group International
MGIH
$18.2M
| $23.5K | ﹤0.01% |
+18,917
| New | +$31.2K |
|
2310
Ceragon Networks
CRNT
$194M
| $23.3K | ﹤0.01% |
11,100
-127,300
| -92% | -$284K |
|
2311
Protalix BioTherapeutics
PLX
$191M
| $23.2K | ﹤0.01% |
12,900
+2,600
| +25% | +$5.32K |
|
2312
Greenland Technologies Holding
GTEC
$13.6M
| $22.6K | ﹤0.01% |
36,900
-800
| -2% | -$882 |
|
|
FMST
2313
Foremost Lithium Resource & Technology
FMST
$27.2M
| $21.6K | ﹤0.01% |
+10,200
| New | +$30.1K |
|
2314
Fathom Holdings
FTHM
$28.2M
| $21K | ﹤0.01% |
+20,800
| New | +$28K |
|
2315
Lineage Cell Therapeutics
LCTX
$257M
| $19.7K | ﹤0.01% |
11,800
+100
| +0.9% | +$173 |
|
|
CRDL
2316
Cardiol Therapeutics
CRDL
$136M
| $18.2K | ﹤0.01% |
19,100
-13,508
| -41% | -$14.1K |
|
2317
MediciNova
MNOV
$65M
| $17.7K | ﹤0.01% |
+13,500
| New | +$18.6K |
|
2318
Destination XL Group
DXLG
$34.7M
| $16.6K | ﹤0.01% |
18,100
-19,700
| -52% | -$20.2K |
|
|
EM
2319
DELISTED
Smart Share Global Ltd
EM
| $15.7K | ﹤0.01% |
13,400
-34,900
| -72% | -$46.5K |
|
|
SLAI
2320
DELISTED
SOLAI Ltd ADS
SLAI
| $14.9K | ﹤0.01% |
+3,171
| New | +$40.9K |
|
|
ORGN
2321
DELISTED
Origin Materials
ORGN
| $14.4K | ﹤0.01% |
2,267
+1,840
| +431% | +$26.9K |
|
2322
NN Inc
NNBR
$272M
| $13.4K | ﹤0.01% |
10,500
-4,800
| -31% | -$7.34K |
|
2323
Rallybio
RLYB
$86.6M
| $13.2K | ﹤0.01% |
+2,413
| New | +$12.4K |
|
2324
Atossa Therapeutics
ATOS
$22.8M
| $10.8K | ﹤0.01% |
+1,220
| New | +$15.4K |
|
|
KAPA
2325
Kairos Pharma
KAPA
$6.1M
| $10.8K | ﹤0.01% |
+15,142
| New | +$14.2K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, Two Sigma Advisers held 2,686 positions worth $51.4B, up 2.9% from $50B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Two Sigma Advisers's Q4 2025 filing shows 375 new, 1,038 increased, 898 reduced and 357 closed positions. Its largest new stake was Kimberly-Clark: 2,442,100 shares worth $246M. The largest sale was Bank of America, an estimated $569M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.
- Two Sigma Advisers's largest Q4 2025 buy was Kimberly-Clark: 2,442,100 shares worth $246M.
- Two Sigma Advisers added most to ServiceNow in Q4 2025, an estimated $512M increase.
- Two Sigma Advisers's biggest Q4 2025 reduction was Bank of America, cutting an estimated $569M.
- Two Sigma Advisers fully exited Nebius Group N.V. in Q4 2025, selling an estimated $257M.
- Two Sigma Advisers's ten largest holdings make up 19% of its $51.4B portfolio in Q4 2025.
- Two Sigma Advisers opened 375 new positions and closed 357 in Q4 2025.
- Two Sigma Advisers's portfolio value rose 2.9% quarter-over-quarter to $51.4B.
Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.